PT1242062E - Gel anidro que compreende nsaid para administracao topica na cavidade oral - Google Patents

Gel anidro que compreende nsaid para administracao topica na cavidade oral

Info

Publication number
PT1242062E
PT1242062E PT00991243T PT00991243T PT1242062E PT 1242062 E PT1242062 E PT 1242062E PT 00991243 T PT00991243 T PT 00991243T PT 00991243 T PT00991243 T PT 00991243T PT 1242062 E PT1242062 E PT 1242062E
Authority
PT
Portugal
Prior art keywords
anidro
nsaid
gel
understanding
oral cavity
Prior art date
Application number
PT00991243T
Other languages
English (en)
Inventor
Massimo Pedrani
Mauro Ajani
Roberto Villa
Original Assignee
Cosmo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cosmo Spa filed Critical Cosmo Spa
Publication of PT1242062E publication Critical patent/PT1242062E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT00991243T 1999-12-29 2000-12-21 Gel anidro que compreende nsaid para administracao topica na cavidade oral PT1242062E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999MI002736A IT1315274B1 (it) 1999-12-29 1999-12-29 Composizioni farmaceutiche per la somministrazione localizzata nelcavo orale di farmaci antiinfiammatori non stereoidei utili per la

Publications (1)

Publication Number Publication Date
PT1242062E true PT1242062E (pt) 2004-10-29

Family

ID=11384215

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00991243T PT1242062E (pt) 1999-12-29 2000-12-21 Gel anidro que compreende nsaid para administracao topica na cavidade oral

Country Status (11)

Country Link
EP (1) EP1242062B1 (pt)
AT (1) ATE271862T1 (pt)
AU (1) AU3162701A (pt)
DE (1) DE60012575T2 (pt)
DK (1) DK1242062T3 (pt)
ES (1) ES2225301T3 (pt)
IT (1) IT1315274B1 (pt)
PT (1) PT1242062E (pt)
SI (1) SI1242062T1 (pt)
TR (1) TR200402015T4 (pt)
WO (1) WO2001049276A2 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2457100A1 (en) * 2001-08-01 2003-02-13 Bristol-Myers Squibb Company Taste masking composition
US7090859B2 (en) 2002-12-13 2006-08-15 Ronald Thomas Haas Ketoprofen compositions and methods of making them
DE102009008094A1 (de) 2009-02-09 2010-08-19 Barnikol-Keuten, Doris, Dr. In situ Haft-Gelbildende Zubereitungen, insbesondere zur topischen Anwendung auf befeuchtete Haut/Schleimhaut
US9132096B1 (en) 2014-09-12 2015-09-15 Alkermes Pharma Ireland Limited Abuse resistant pharmaceutical compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2707878C2 (de) * 1977-02-24 1986-01-30 Kali-Chemie Pharma Gmbh, 3000 Hannover Verwendung von Mono- und/oder Diglyceriden mittelkettiger Fettsäuren
US4933172A (en) * 1988-10-06 1990-06-12 Warner-Lambert Co. Method of and compositions for treating destructive periodontal disease
US4883660A (en) * 1988-10-17 1989-11-28 Thames Pharmacal Co., Inc. Gel bases for pharmaceutical compositions
US5192802A (en) * 1991-09-25 1993-03-09 Mcneil-Ppc, Inc. Bioadhesive pharmaceutical carrier
DK196591D0 (da) * 1991-12-05 1991-12-05 Mouritsen & Elsner Aps Anvendelse af en kendt kemisk forbindelse til fremstilling af et farmaceutisk paraeparat til topisk applikation

Also Published As

Publication number Publication date
IT1315274B1 (it) 2003-02-03
DK1242062T3 (da) 2004-11-29
EP1242062B1 (en) 2004-07-28
AU3162701A (en) 2001-07-16
WO2001049276A3 (en) 2001-12-13
SI1242062T1 (en) 2004-10-31
DE60012575D1 (de) 2004-09-02
DE60012575T2 (de) 2005-07-21
ES2225301T3 (es) 2005-03-16
TR200402015T4 (tr) 2004-10-21
WO2001049276A2 (en) 2001-07-12
ITMI992736A0 (it) 1999-12-29
ITMI992736A1 (it) 2001-06-29
ATE271862T1 (de) 2004-08-15
EP1242062A2 (en) 2002-09-25

Similar Documents

Publication Publication Date Title
ATE252892T1 (de) Aus mehreren einzeleinheiten zusammengesetzte arzneimittel mit nicht-steroidalen wirkstoffen (nsaids)
MY144292A (en) Method of reducing oral tissue inflammation using magnolia extract
NO20062504L (no) Sammensetninger og doseringsformer for forbedret absorpsjon
ES2167061T3 (es) Formas de dosificacion para mejorar la disfuncion erectil en pacientes de sexo masculino.
BRPI0408999A (pt) comprimidos prensados de multiparticulados de liberação oral prolongada
ID27504A (id) Formulasi oral baru
AR037592A1 (es) Formulaciones farmaceuticas de 5,7,14-triazatetraciclo (10.3.1.02,11.04,9)-hexadeca-2(11),3,5,7,9-pentaeno
AR048318A1 (es) Formulaciones de matriz orales que comprenden licarbazepina
EE200300371A (et) Peroraalselt ja paikselt manustatavad farmatseutilised kopmositsioonid
ATE455539T1 (de) Darreichungsformen mit verlängerter wirkstofffreisetzung
AR046036A1 (es) Composiciones de risedronato y metodos para su uso
WO2004100893A3 (en) Methods for treatment of inflammatory diseases using ct-3 or analogs thereof
PT1242062E (pt) Gel anidro que compreende nsaid para administracao topica na cavidade oral
RS50693B (sr) Stabilni farmaceutski gel diklofenak natrijuma
UY29201A1 (es) Sistema de aplicacion localizada y residual de medicamentos intra oral
WO2004033484A3 (en) Use of stable glutamine derivatives to improve drug absorption
PT927031E (pt) Composicao farmaceutica que contem nimesulide para administracao por via oral
BR0313305A (pt) Agente analgésico para indivìduos recém-nascidos ou fetais
DK1276477T3 (da) Medikamenter indeholdende pantothensyre til behandlingen af inflammatorisk ledsygdom
DE59908258D1 (de) Blister enthaltend ein transdermales therapeutisches system und eine einzeldosierte darreichungsform
AR023151A1 (es) Preparado farmaceutico que contiene como principio activo, por lo menos una parte de acido acetilsalicilico
ES2189639B1 (es) Composicion acuosa que contiene acido acetilsalicilico.
EA200300007A1 (ru) Композиция для лечения гриппа, способ ее стабилизации
DE60035351D1 (de) Topische behandlung von autoimmunerkrankungen der mundhöhle durch azathioprin
AR031525A1 (es) Uso de una composicion que comprende un compuesto de modafinil para el tratamiento de la enfermedad de hiperactividad con déficit de atencion y la fatiga de esclerosis multiple, composiciones farmaceuticas, un envase terapeutico, metodo de identificacion de un compuesto que modula selectivamente la